Insufficient scRNA-seq data for expression of ALG12 at single-cell level.
Insufficient scRNA-seq data for expression of ALG12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 803.49 | 1445 / 1445 | 100% | 9.73 | 183 / 183 |
prostate | 100% | 1032.61 | 245 / 245 | 100% | 11.97 | 501 / 502 |
lung | 100% | 841.77 | 578 / 578 | 100% | 9.02 | 1151 / 1155 |
stomach | 100% | 858.27 | 359 / 359 | 100% | 9.73 | 285 / 286 |
intestine | 100% | 893.97 | 966 / 966 | 99% | 8.84 | 522 / 527 |
skin | 100% | 785.87 | 1809 / 1809 | 99% | 9.75 | 467 / 472 |
pancreas | 100% | 672.54 | 328 / 328 | 98% | 6.34 | 175 / 178 |
breast | 100% | 765.22 | 459 / 459 | 98% | 8.50 | 1099 / 1118 |
kidney | 100% | 843.97 | 89 / 89 | 98% | 8.69 | 884 / 901 |
thymus | 100% | 1393.51 | 653 / 653 | 98% | 8.72 | 590 / 605 |
brain | 98% | 416.41 | 2602 / 2642 | 99% | 5.60 | 697 / 705 |
bladder | 100% | 827.71 | 21 / 21 | 97% | 7.29 | 490 / 504 |
uterus | 100% | 978.11 | 170 / 170 | 95% | 6.81 | 435 / 459 |
ovary | 100% | 850.13 | 180 / 180 | 95% | 5.59 | 407 / 430 |
liver | 100% | 705.60 | 226 / 226 | 92% | 7.18 | 375 / 406 |
adrenal gland | 100% | 761.78 | 258 / 258 | 78% | 3.53 | 180 / 230 |
adipose | 100% | 708.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 825.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.40 | 1 / 1 |
blood vessel | 100% | 789.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 411.06 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 570.21 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.09 | 79 / 80 |
peripheral blood | 96% | 536.44 | 895 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 7.24 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 4.18 | 23 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0098553 | Cellular component | lumenal side of endoplasmic reticulum membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0000009 | Molecular function | alpha-1,6-mannosyltransferase activity |
GO_0052917 | Molecular function | dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase |
GO_0000030 | Molecular function | mannosyltransferase activity |
Gene name | ALG12 |
Protein name | Mannosyltransferase (EC 2.4.1.-) Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87) |
Synonyms | PP14673 |
Description | FUNCTION: Adds the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. |
Accessions | ENST00000330817.11 Q9BV10 H7C4I6 ENST00000492791.1 H7C5R7 ENST00000486602.1 |